Carmelo A. Juárez-Castelló

Dr. Carmelo A. Juárez-Castelló

Universidad de La RIoja
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2019 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
FAFernando Antonanzas
Fernando Antonanzas
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló
RLReyes Lorente
Reyes Lorente
RRRoberto Rodríguez-Ibeas
Roberto Rodríguez-Ibeas

22 February 2011 in Health Economics, Policy and Law
Verified
Journal Article
Closed access
PDF file
FAFernando Antonanzas
Fernando Antonanzas
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló
RRRoberto Rodriguez-Ibeas
Roberto Rodriguez-Ibeas
In this paper, we characterise the risk-sharing contracts that health authorities can design when they face a regulatory decision on drug pricing and reimbursement in a context of uncertainty. We focus on two types of contracts. On the one hand, the health authority can reimburse the firm for each treated patient regardless of health outcomes (non risk-sharing). Alternatively, the health authority can pay for the drug only when the patient is cured (risk-sharing contract). The optimal contract depends on the trade-off between the monitoring costs, the marginal production cost and the utility derived from treatment. A non-risk-sharing agreement will be preferred by the health authority, if patients who should not be treated impose a relatively low cost to the health system. When this cost is high, the health authority would prefer a risk-sharing agreement for relatively low monitoring costs.

7 May 2009 in Health Economics
Verified
Journal Article
Closed access
PDF file
FAFernando Antonanzas
Fernando Antonanzas
RRRoberto Rodríguez‐Ibeas
Roberto Rodríguez‐Ibeas
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló
FHFlorencia Hutter
Florencia Hutter
RLReyes Lorente
Reyes Lorente
MPMariola Pinillos
Mariola Pinillos

8 November 2014 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
FAF. Antoñanzas
F. Antoñanzas
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló
RRR. Rodríguez-Ibeas
R. Rodríguez-Ibeas

20 May 2011 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
FAFernando Antoñanzas
Fernando Antoñanzas
RRR. Rodríguez-Ibeas
R. Rodríguez-Ibeas
MHM. F. Hutter
M. F. Hutter
RLR. Lorente
R. Lorente
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló
MPM. Pinillos
M. Pinillos

15 February 2018 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
FAFernando Antoñanzas
Fernando Antoñanzas
RRRoberto Rodríguez-Ibeas
Roberto Rodríguez-Ibeas
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló